Advanced search
Publication Cover
International Journal of Hyperthermia Volume 34, 2018 - Issue 5
Submit an article Journal homepage
1,334
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of advanced epithelial and recurrent ovarian carcinoma: a single center experience

Maja J. PavlovSchool of Medicine, University of Belgrade, Belgrade, Serbia; ;Department for Colorectal and Pelvic Surgery, First Surgical Clinic, Clinical Center of Serbia, Belgrade, Serbia; View further author information
,
Miljan S. CeranicSchool of Medicine, University of Belgrade, Belgrade, Serbia; ;Department for Colorectal and Pelvic Surgery, First Surgical Clinic, Clinical Center of Serbia, Belgrade, Serbia; View further author information
,
Stojan M. LatincicDepartment for Colorectal and Pelvic Surgery, First Surgical Clinic, Clinical Center of Serbia, Belgrade, Serbia; View further author information
,
Predrag V. SabljakSchool of Medicine, University of Belgrade, Belgrade, Serbia; ;Department for Esophagogastric Surgery, First Surgical Clinic, Clinical Center of Serbia, Belgrade, Serbia; View further author information
,
Dragutin M. KecmanovicSchool of Medicine, University of Belgrade, Belgrade, Serbia; ;Department for Colorectal and Pelvic Surgery, First Surgical Clinic, Clinical Center of Serbia, Belgrade, Serbia; Correspondence[email protected]
View further author information
&
Paul H. SugarbakerCenter for Gastrointestinal Malignancies, MedStar Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC, USAView further author information
Pages 564-569 | Received 31 Oct 2016, Accepted 20 Aug 2017, Published online: 07 Sep 2017

References

  • Jelovac D, Armstrong DK. (2011). Recent progress in the diagnosis and treatment of ovarian cancer. CA Cancer J Clin 61:183–203.
  • Fleming GF, Seidman J, Lengyel E, Epithelial ovarian cancer. In: Barakat RR, Markman M, Randall ME, eds. Principles and Practice of Gynecologic Oncology, 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2013:757–847.
  • Lancaster JM, Powell CB, Kauff ND, et al. (2007). Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol 107:159–62.
  • Ozols RF. (2005). Treatment goals in ovarian cancer. Int J Gynecol Cancer 15:3–11.
  • Spiliotis J, Halkia E, Lianos E, et al. (2015). Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study. Ann Surg Oncol 22:1570–5.
  • Chi DS, Liao JB, Leon LF, et al. (2001). Identification of prognostic factors in advanced ovarian epithelial carcinoma. Gynecol Oncol 82:532–7.
  • Chi DS, Eisenhauer EL, Lang J, et al. (2006). What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma? Gynecol Oncol 103:559–64.
  • Bristow RE, Tomacruz RS, Armstrong DK, et al. (2002). Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20:1248–59.
  • Hoskins WJ. (1994). Epithelial ovarian carcinoma: principles of primary surgery. Gynecol Oncol 55:S91–6.
  • Redman JR, Petroni GR, Saigo PE, et al. (1986). Prognostic factors in advanced ovarian carcinoma. J Clin Oncol 4:515–23.
  • Chi DS, Eisenhauer EL, Zivanovic O, et al. (2009). Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. Gynecol Oncol 114:26–31.
  • Whitney CW, Spirtos N. (2009). Gynecologic Oncology Group Surgical Procedures Manual. Philadelphia: Gynecologic Oncology Group.
  • Sugarbaker PH. (1996) Peritoneal carcinomatosis. Principles of management. Boston: Kluver Academic.
  • Sugarbaker PH, Chang D. (1999). Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 6:727–31.
  • National Cancer Institute. Common terminology criteria for adverse events v.4.0 (CTCAE). Available from: http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm. [last accessed 20 Jun 2012].
  • Chua TC, Robertson G, Liauw W, et al. (2009). Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results. J Cancer Res Clin Oncol 135:1637–45.
  • Bakrin N, Bereder JM, Decullier E, et al. (2013). Peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients. Eur J Surg Oncol 39:1435–43.
  • Armstrong D, Bundy B, Wenzel L, et al. (2006). Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 354:34–43.
  • Harter P, Hahmann M, Lueck HJ, et al. (2009). Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis. Ann Surg Oncol 16:1324–30.
  • Coccolini F, Campanati L, Catena F, et al. (2015). Hyperthermic intraperitoneal chemotherapy with cisplatin and paclitaxel in advanced ovarian cancer: a multicenter prospective observational study. J Gynecol Oncol 1:54–61.
  • Halkia E, Spiliotis J, Sugarbaker P. (2012). Diagnosis and management of peritoneal metastases from ovarian cancer. Gastroenterol Res Pract 2012:541842.
  • Tan GH, Ong WS, Chia CS, et al. (2016). Does early post-operative intraperitoneal chemotherapy (EPIC) for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) make a difference? Int J Hyperthermia 32:281–8.
  • McConnell YJ, Mack LA, Francis WP, et al. (2013). HIPEC + EPIC versus HIPEC-alone: differences in major complications following cytoreduction surgery for peritoneal malignancy. J Surg Oncol 107:591–6.
  • Sánchez-García S, Villarejo-Campos P, Padilla-Valverde D, et al. (2016). Intraperitoneal chemotherapy hyperthermia (HIPEC) for peritoneal carcinomatosis of ovarian cancer origin by fluid and CO2 recirculation using the closed abdomen technique (PRS-1.0 Combat): a clinical pilot study. Int J Hyperthermia 32:488–95.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.